ClinicalTrials.Veeva

Menu

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

OHSU Knight Cancer Institute logo

OHSU Knight Cancer Institute

Status

Completed

Conditions

Melanoma

Treatments

Device: VivaScope System

Study type

Observational

Funder types

Other

Identifiers

NCT01556503
CPC-11033-L (Other Identifier)
IRB00006939

Details and patient eligibility

About

The purpose of this study is to show how well a new device, confocal microscope, works to detect malignant melanoma, a type of skin cancer.

Enrollment

24 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 12 or older
  • Patient who has already been selected by their dermatologist for biopsy of a suspicious pigmented lesion and who consents to participate in the study
  • Signed informed consent

Exclusion criteria

  • Age < 12 years

Trial design

24 participants in 1 patient group

Pigmented Lesion
Description:
Patients identified as having a concerning pigmented lesion and the physician believes it is appropriate to biopsy to rule out melanoma.
Treatment:
Device: VivaScope System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems